Swipe om te navigeren naar een ander artikel
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The constructs evaluated in investigating association between psychosocial factors and cancer survival has varied between studies, and factors related to quality of life (QOL) have shown contradictory results. We investigated the effect of socioeconomic and early QOL and psychological factors on disease-free time and survival in localized prostate cancer.
A consecutive sample of patients with localized prostate cancer (T1–3, N0, M0) treated with external beam radiotherapy completed validated questionnaires on coping with cancer (the Ways of Coping Questionnaire WOC-CA), anger expression (the Anger Expression Scale), life events (the Life Experience Survey), and various aspects of QOL (the Rotterdam Symptom Checklist, the Depression Scale DEPS, the EORTC QLQ-C30, the LENT-SOMA outcome measure) approximately 4.5 months after diagnosis. Cox regression analyses were used to determine the predictors of the disease-free and overall survival times measured from the date of diagnosis to the date of a PSA-relapse and date of death.
After controlling for biological prognostic factors, age, and adjuvant hormonal therapies, moderate and high socioeconomic status and an increased level of pain predicted longer survival, whereas an increased level of prostate-area symptoms and fatigue and, especially, reports of no/few physical symptoms were predictors of a shorter survival time. A longer PSA-relapse-free time was predicted by Cognitive Avoidance/Denial coping, whereas problems in social functioning, hopelessness, and an excellent self-reported QOL predicted a shorter PSA-relapse-free time.
Higher socioeconomic status was prognostic for longer survival, as previously reported. Patients with a seemingly good QOL (few physical complaints, excellent self-reported QOL) had poorer prognoses. This association may due to the survival decreasing effect of emotional non-expression; patients with high emotional non-expression may over-report their wellbeing in simple measures, and thus actually be in need of extra attention and care.
Lehto, U.-S., Ojanen, M., Dyba, T., et al. (2007). Baseline psychosocial predictors of survival in localized melanoma. J Psychosomatics Research, 63, 9–15. CrossRef
Chida, Y., Hamer, M., Wardle, J., et al. (2008). Do stress-related psychosocial factors contribute to cancer incidence and survival? Nature Reviews Clinical Oncology, 5(8), 466–475. CrossRef
Kristenson, M., Eriksen, H. R., Sluiter, J. K., et al. (2004). Psychobiological mechanisms of socioeconomic differences in health. Social Science & Medicine, 58, 1511–1522. CrossRef
Garssen, B., & Remie, M. (2004). Different concepts or different words? Concepts related to non-expression of negative emotions. In In I. Nyclicek, L. Temoshok, & A. Vingerhoets (Eds.) Emotional expression and health. (pp. 117–136) Hove and New York: Brunner-Routledge.
Temoshok, L. (1987). Personality, coping style, emotion and cancer: Towards an integrative model. Cancer Survial, 6, 545–567.
Gross, J. (1989). Emotional expression in cancer onset and progression. Social Science & Medicine, 28, 1239–1248. CrossRef
Greer, S., Morris, T., & Pettingale, K. W. (1979). Psychosocial response to breast cancer; effect on outcome. Lancet, ii, 785–787. CrossRef
Nausheen, B., Gidron, Y., Peveler, R., et al. (2009). Social support and cancer progression: A systematic review. J Psychosomatic Research, 67, 403–415. CrossRef
Penson, D., Rossignol, M., Sartor, A., et al. (2008). Prostate cancer: Epidemiology and health related quality of life. Urology, 72(Supplement 6A), 3–11. CrossRef
van Leeuwen, P. J., Kranse, R., Hakulinen, T., et al. (2013). Impacts of a population-based prostate cancer screening programme on excess total mortality rates in men with prostate cancer: A randomized controlled trial. J Med Screen, 20(1), 33–38. CrossRef
Myers, L. B., & Derakshan, N. (2004). The repressive coping style and avoidance of negative affect. In I. Nyclicek, L. Temoshok, & A. Vingerhoets (Eds.) Emotional expression and health. (pp. 169–184) Hove and New York: Brunner-Routledge.
Dolbeaut, S., Szporn, A., & Holland, J. C. (1999). Psycho-oncology: Where have we been? Where are we going? European Journal of Cancer, 35, 1554–1558. CrossRef
Kiecolt-Glaser, J. K., & Glaser, R. (1999). Psychoneuroimmunology and cancer: Fact or fiction? European Journal of Cancer, 35, 1581–1586. CrossRef
Folkman, S., Chesney, M., McKusick, L., et al. (1991). Translating coping theory into an intervention. In J. Eckenrode (Ed.) The social context of coping. (pp. 239–260) New York: Plenum Press.
Eysenck, H. J. (1994). Cancer, personality and stress: Prediction and prevention. Advances in Behaviour Research and Therapy, 16, 167–215. CrossRef
Dunkel-Schetter, C. (1992) Patterns of coping with cancer. Health psychology, 11(2), 79–87.
Janisse, M. P., Editor (1988). The experience, expression, and control of anger. In Individual differences, stress, and health psychology (pp. 89–108). New York: Springer. CrossRef
deHaes, J., van Knippenberg, F., & Neijt, J. (1990). Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. British Jounal of Cancer, 62, 1034–1038. CrossRef
Cox, D. (1972). Regression models and life-tables (with discussion). Statistical Methodology, 34, 187–220.
Schoenfeld, D. (1982). Partial residuals for the proportional hazards regression model. Biometrika, 69, 239–241. CrossRef
Pokhrei, A., Martikainen, P., Pukkala, E., et al. (2010). Education, survival and avoidable deaths in cancer patients in Finland. British Journal of Cancer, 103, 1109–1114. CrossRef
Myers, L., & Vetere, A. (1997). Repressors’ responses to health-related questionnaires. British Journal of Health Psychology, 2, 245–257. CrossRef
- Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer
- Springer International Publishing